Koyama R, Kataoka H, Tanaka Y, Nakatsugi S, Furukawa M
Osaka Research Laboratory, Sawai Pharmaceutical Co. Ltd, Osaka, Japan.
J Pharm Pharmacol. 1999 Jul;51(7):817-24. doi: 10.1211/0022357991773014.
During investigations on the effect of caffeine on ibuprofen-induced gastric mucosal lesions in rats, we have found that caffeine (p.o.) inhibits the development of ibuprofen-induced gastric lesions in a dose-dependent manner (ED50 18.4 mg kg(-1)). To investigate this protective effect of caffeine, we have studied the effect of caffeine on HCl-ethanol-induced gastric mucosal lesions with or without indomethacin pretreatment. Caffeine inhibited the development of HCl-ethanol-induced gastric lesions with and without indomethacin pretreatment. These results indicate that caffeine did not act as a mild irritant but, on the contrary, had protective effects. We measured the gastric mucosal prostaglandin E2 (PGE2) concentrations and gastric mucosal blood flow, as representative protective factors for gastric mucosa. Caffeine did not affect the gastric mucosal PGE2 concentrations 4h after administration of ibuprofen. However, topical administration of caffeine resulted in an increase in gastric mucosal blood flow, as measured by laser Doppler flowmetry. We investigated the gastric acid secretion and gastric mucosal myeloperoxidase activity as representative aggressive factors for gastric mucosa. When caffeine was administered intraduodenally in pylorus-ligated rats, gastric acid secretion decreased in a dose-dependent manner, with an ED50 of 44.9 mg kg(-1). Caffeine decreased ibuprofen-induced gastric myeloperoxidase activity in a dose-dependent manner, with an ED50 of 9.1 mg kg(-1). These findings indicate that caffeine, at least in rats, may inhibit the development of acute gastric mucosal injury. The mechanisms underlying the protective actions of caffeine are unclear, but may be related in part to an increase in gastric mucosal blood flow and suppression of neutrophil activation.
在研究咖啡因对布洛芬诱导的大鼠胃黏膜损伤的影响时,我们发现咖啡因(口服)以剂量依赖性方式抑制布洛芬诱导的胃损伤的发展(半数有效剂量为18.4 mg·kg⁻¹)。为了研究咖啡因的这种保护作用,我们研究了咖啡因对有或没有吲哚美辛预处理的盐酸 - 乙醇诱导的胃黏膜损伤的影响。无论有无吲哚美辛预处理,咖啡因均抑制盐酸 - 乙醇诱导的胃损伤的发展。这些结果表明,咖啡因并非起轻度刺激物的作用,相反,具有保护作用。我们测量了胃黏膜前列腺素E2(PGE2)浓度和胃黏膜血流量,作为胃黏膜的代表性保护因子。给予布洛芬4小时后,咖啡因不影响胃黏膜PGE2浓度。然而,通过激光多普勒血流仪测量,局部应用咖啡因可导致胃黏膜血流量增加。我们研究了胃酸分泌和胃黏膜髓过氧化物酶活性,作为胃黏膜的代表性攻击因子。当在幽门结扎的大鼠十二指肠内给予咖啡因时,胃酸分泌以剂量依赖性方式减少,半数有效剂量为44.9 mg·kg⁻¹。咖啡因以剂量依赖性方式降低布洛芬诱导的胃髓过氧化物酶活性,半数有效剂量为9.1 mg·kg⁻¹。这些发现表明,至少在大鼠中,咖啡因可能抑制急性胃黏膜损伤的发展。咖啡因保护作用的潜在机制尚不清楚,但可能部分与胃黏膜血流量增加和中性粒细胞活化的抑制有关。